Suresh Babu Mallekavu Chikkadasappa, G. Kanakasetty, Lokesh Kadabur Nagendrappa, S. Rao
{"title":"转移性非小细胞肺癌患者对培美曲塞的异常皮肤反应","authors":"Suresh Babu Mallekavu Chikkadasappa, G. Kanakasetty, Lokesh Kadabur Nagendrappa, S. Rao","doi":"10.5530/ogh.2017.6.1.11","DOIUrl":null,"url":null,"abstract":"Pemetrexed, a drug used in lung cancer and pleural mesotheliomas is mainly associated with hematological toxicities. Cutaneous toxicities, although well known are rare. This is a case of a metastatic adenocarcinoma lung with recurrent and localised skin lesions following each cycle of pemetrexed, which is the first report of its kind.","PeriodicalId":166206,"journal":{"name":"Oncology, Gastroenterology and Hepatology Reports","volume":"107 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2016-11-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Unusual Cutaneous reactions to Pemetrexed in a Patient with Metastatic non-small cell Lung Cancer\",\"authors\":\"Suresh Babu Mallekavu Chikkadasappa, G. Kanakasetty, Lokesh Kadabur Nagendrappa, S. Rao\",\"doi\":\"10.5530/ogh.2017.6.1.11\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Pemetrexed, a drug used in lung cancer and pleural mesotheliomas is mainly associated with hematological toxicities. Cutaneous toxicities, although well known are rare. This is a case of a metastatic adenocarcinoma lung with recurrent and localised skin lesions following each cycle of pemetrexed, which is the first report of its kind.\",\"PeriodicalId\":166206,\"journal\":{\"name\":\"Oncology, Gastroenterology and Hepatology Reports\",\"volume\":\"107 1\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2016-11-20\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Oncology, Gastroenterology and Hepatology Reports\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5530/ogh.2017.6.1.11\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Oncology, Gastroenterology and Hepatology Reports","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5530/ogh.2017.6.1.11","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Unusual Cutaneous reactions to Pemetrexed in a Patient with Metastatic non-small cell Lung Cancer
Pemetrexed, a drug used in lung cancer and pleural mesotheliomas is mainly associated with hematological toxicities. Cutaneous toxicities, although well known are rare. This is a case of a metastatic adenocarcinoma lung with recurrent and localised skin lesions following each cycle of pemetrexed, which is the first report of its kind.